Financing, Equity Capital Markets

Edgewise Therapeutics

04/25
|
$200.0 Million
edgewise
Piper Sandler served as bookrunner for Edgewise Therapeutics on its registered direct offering
Sub-Type
Registered Direct
Sub-Sector
Biopharma